NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

How could you know what action FDA will take? When was the ASCO presentation? It was last June. In June, Dr. Bosch said the number of patients who received DCVax-L was over 600. In August, Les said the number was 800. In three months, about 200 patients received the treatment through compassionate program. Does 200 in three months match the manufacturing capacity of Adevent Bio?

I cannot believe you and your buddies still think there would be no approval from MHRA. Don't even think about it. It will be approved 100%. My only question is. Is the approval about DCVax-L + Poly-ICLC or DCVax-L + Poly-ICLC + Keytruda? I don't even consider DCVax-L alone case.